Bank of New York Mellon »

Sutro Biopharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 41k 33.20

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Sutro Biopharma

Perceptive Advisors
BVF
Affinity Asset Advisors
BlackRock
Samsara BioCapital
Kynam Capital Management
OrbiMed Advisors
Balyasny Asset Management
Vanguard Capital Management
Eventide Asset Management
Velan Capital Investment Management
Woodline Partners
ADAR1 Capital Management
Geode Capital Management
Acadian Asset Management

View all funds holding Sutro Biopharma